Skip to content
10-Q

Quarterly Report

Yubo International Biotech Ltd YBGJ

0001640334-24-001693

← back to feed
Filed
Nov 13, 2024 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2024 · Nov 10, 2024 119.82M sh
Cash And Equivalents Q3 2024 · Sep 30, 2024 $8.03K
Stockholders Equity Q3 2024 · Sep 30, 2024 −$3.13M
Stockholders Equity Q3 2024 · Dec 31, 2023 −$1.84M
Current Liabilities Q3 2024 · Sep 30, 2024 $4.49M
Current Liabilities Q3 2024 · Dec 31, 2023 $3.4M
Total Liabilities Q3 2024 · Sep 30, 2024 $4.7M
Total Liabilities Q3 2024 · Dec 31, 2023 $3.51M
Current Assets Q3 2024 · Sep 30, 2024 $723.97K
Current Assets Q3 2024 · Dec 31, 2023 $725.24K
Total Assets Q3 2024 · Sep 30, 2024 $1.65M
Total Assets Q3 2024 · Dec 31, 2023 $1.67M
Net Income Q3 2024 · Jun 30, 2024 −$598.35K
Net Income Q3 2024 · Mar 31, 2024 −$409.51K
Net Income Q3 2024 · Sep 30, 2023 $6.29K
Net Income Q3 2024 · Sep 30, 2023 −$677.7K
Net Income Q3 2024 · Jun 30, 2023 −$367.33K
Net Income Q3 2024 · Mar 31, 2023 −$316.67K
Shares Diluted Q3 2024 · Sep 30, 2023 119.82M sh
Shares Diluted Q3 2024 · Sep 30, 2023 119.82M sh
Operating Cash Flow Q3 2024 · Sep 30, 2023 −$180.62K
Eps Diluted Q3 2024 · Sep 30, 2023 $0.00
Eps Diluted Q3 2024 · Sep 30, 2023 −$0.01
Operating Income Q3 2024 · Sep 30, 2023 $6.42K
Operating Income Q3 2024 · Sep 30, 2023 −$677.39K
Gross Profit Q3 2024 · Sep 30, 2023 $344.08K
Gross Profit Q3 2024 · Sep 30, 2023 $401.12K
Cost Of Revenue Q3 2024 · Sep 30, 2023 $84.43K
Cost Of Revenue Q3 2024 · Sep 30, 2023 $181.27K
Revenue Q3 2024 · Sep 30, 2023 $428.51K
Revenue Q3 2024 · Sep 30, 2023 $582.39K